Massachusetts General Hospital (MGH) in the US has formed a research partnership with Siemens Healthineers to establish a Therapy Command Center.
This centre is designed to implement theranostics across the hospital and its facilities in Massachusetts, Maine, and New Hampshire.
Go deeper with GlobalData
It will facilitate data collection, provide real-time monitoring, and support healthcare professionals in making informed patient care decisions.
Theranostics combines molecular imaging techniques to assess disease progression and evaluate treatment efficacy.
MGH nuclear medicine and molecular imaging chief Umar Mahmood said: “The Therapy Command Centre helps provide a framework that will enable the integration of a wide variety of patient imaging and laboratory data, combined with population-based data for enhanced individual patient outcomes.
“This collaboration will help expand theranostics across the region, advancing personalised medicine through precision diagnoses and tailored therapies.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataResearchers from Siemens Healthineers and MGH will use advanced imaging technology, including the Biograph Vision Quadra and Biograph Trinion positron emission tomography/computed tomography (PET/CT) scanners.
Their research aims to understand the effects of radiation on molecular and biological processes, as well as assess toxicity levels in both cancerous and healthy tissues of patients undergoing radiopharmaceutical therapy.
This knowledge is crucial for advancing personalised medicine, according to the company.
Siemens Healthineers Molecular Imaging James Williams said: “This research collaboration, which is based on a relationship between Siemens Healthineers and Massachusetts General Hospital that spans more than 20 years, will enable innovations along the patient’s clinical pathway, provide precision diagnoses, and deliver highly effective forms of customised therapy.”
In July 2024, Redhill Cancer Hospital, part of RVL Healthcare, signed a memorandum of understanding (MoU) with Siemens Healthineers to create a Cancer Centre and Research Park in Nairobi, Kenya.
